Welcome to Our New Members
Entering 2018, Oslo Cancer Cluster welcomes four new members to the fold. Cellmover, Bryn Aarflot, Kuehne + Nagel and Mercuri Urval are our new cluster members.
The Importance of Getting There
Founded in 1890, Kuehne + Nagel operates from 9 locations in Norway, offering tailored logistics solutions for different industries, including for healthcare and pharmaceuticals shipments. Simply put, their expertise is getting things where they are supposed to go – safely and in compliance. They are one of the leading logistics providers in the world, with over 74 000 employees and 1 300 offices spread all over the globe.
For Oslo Cancer Cluster members, Kuehne+Nagel’s a special competence can be applied to help us reach our shared goal of accelerating the development of innovative cancer treatments. They are CEIV-certified (IATA airfreight pharmaceutical), and WHO GDP (good distribution practices) compliant for pharmaceutical products and specialized in the distribution of pharmaceutical and healthcare shipments. For example, biotechs can have very specific requirements when it comes to transport of products. In many instances, it is crucial to transport biological tissue at a certain temperature under certain conditions.
Protecting and Developing Innovation
Another company rich in tradition is the Norwegian firm Bryn Aarflot. They are a full-service Intellectual Property (IP) firm with a total of 45 people located in central Oslo. Their diverse IP practice areas include strategic counselling, intellectual property creation, capture and clearance through to protection, commercialization, enforcement and maintenance, contract drafting and negotiations, as well as IP litigation.
Their approach is to get to know the client’s business and understand their technology, products and goals, and counsel them on how to utilize the intellectual property to generate revenue and increase market power. This is a positive addition to the Cancer Cluster community, where biotechs innovate on the basis of their own intellectual property.
Helping Start-Ups
Cellmover is truly a company that goes to the core of what we do here at Oslo Cancer Cluster. It’s a Biotech start-up, led by Oslo University Hospital cancer specialist Marit Inngjerdingen. Cellmover’s goal is to develop immunotherapeutic products directed at the treatment of cancer. They specifically design products to enhance survival, activity, and targeting of immune cells used for cell therapy.
As a Oslo Cancer Cluster member, Cell Mover can benefit from all the help our cluster can provide. In the cluster environment, it is easier to meet and learn from companies with similar technologies, or it could prompt creative ideas from companies working with something quite different. The benefits from learning the necessary “know-hows” to turn a start-up into a successful business and develop cancer treatment.
Do You Need Help Recruiting?
If you work with cancer research, there is one thing you certainly need and that is competent people. Mercuri Urval exists to secure that organizations always have the right people in place to produce the best possible result. They are a leading – Stockholm based – global Executive Search, Professional Recruitment and Talent Advisory firm. One of their fields of expertise is recruitment within the Life Sciences. For more than 50 years Mercuri Urval has recruited human resources for the healthcare industry.
